Theravance Story Overview

THRX -- USA Stock  

null 9.81  9.81  9,223,372,036,855%

Macroaxis does not monitor all media channels or aggregates social signals for Theravance. But even though we do not provide professional-grade financial sentiment analysis on Theravance, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Theravance. Also please take a look at World Market Map.
Breakfast Technical Briefing on Application Software Stocks -- FireEye ...
Under review this morning are the following equities FireEye Inc. , Fortinet Inc. , Innoviva Inc. , and Intuit Inc. . Daily Stock Tracker published free research reports on these stocks today at.

Read More...   

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Theravance

few hours ago at 
Fs Capital Partners Vi Lowered Its Boot Barn Holdings Stake Theravance Biopharma s Sentiment Is 1.35
San TimesFull coverage
over a week ago at 
As Theravance Biopharma Market Valuation Declined, Shareholder Senzar Asset Management Has Upped ...
Thorold NewsFull coverage
over two weeks ago at 
Theravance Biopharma Receives Buy Rating from Needham Company LLC
registrarjournal.comCould Theravance Biopharma, Inc. See a Reversal After Having Formed Several Months Wedge Down Chart ... Press TelegraphTheravance Biopharmas Buy Rating Reaffirmed at Needham Company LLC Enterprise LeaderFull coverage
over two weeks ago at 
GlaxoInnoviva File for Approval of Trelegy Ellipta in Japan
zacks News
Zacks.comFull coverage
over three weeks ago at 
Heres What to Focus on Theravance Biopharma Inc
Alpha Beta StockFull coverage
over a month ago at 
Theravance Biopharmas Buy Rating Reiterated at Needham Company LLC
registrarjournal.comFull coverage
over a month ago at 
Have a look on data XTL Biopharmaceuticals Ltd. , Targa Resources Corp. , Advanced ...
Thestreet News
The Stock Street Full coverage
over a month ago at 
Theravance Biopharma, Inc. has analysts on the Bullish side this week.
BZ WeeklyHow Many Theravance Biopharma, Inc. s Analysts Are Bearish ReuropeZacks Analysts Anticipate Theravance Biopharma Will Post Quarterly Sales of 5.74 Million registrarjournal.comFull coverage
over a month ago at 
EPS for Theravance Biopharma, Inc. Expected At -1.29
NMSU HeraldTheravance Biopharma, Inc. EPS Estimated At -1.29 Finance News DailyGoldman Sachs Group Inc. Cuts Position in Theravance Biopharma Week HeraldFull coverage
Theravance Biopharma Highlights Approval of Expanded Indication in the US for Once-Daily Trelegy Ellipta for ....businessinsider News
Markets InsiderFull coverage
over two months ago at 
Institutional Investors Sentiment Indicator of Theravance Biopharma Improves in Q4 2017
Frisco FastballTheravance Biopharma Q4 2017 Sentiment Change ReuropeMufg Americas Holdings Increased Laboratory Amer Hldgs Position Theravance Biopharma Has 1.31 ... UtahHerald.comFull coverage
over three months ago at 
Today Theravance Biopharma, Inc. Stock Rises
ReuropeTheravance Biopharma Inc. Moves Higher on Volume Spike for March 01 Equities.comCould Theravance Biopharma, Inc. See a Reversal After This Very Strong Session Frisco FastballFull coverage
over three months ago at 
Innoviva Inc RMI Climbing Towards Key Levels
Shares of Innoviva Inc have seen the Relative Momentum Indicator climb higher over the past 5 sessions. When this occurs, traders will be watching closely to see if the price breaks through a key level into overbought territory.

Did you try this?

Run Money Flow Index Now

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Money Flow Index

Shares Owned by Insiders

Shares Owned by Insiders Comparative Analysis
  Shares Owned by Insiders 
      Theravance Comparables 
Theravance is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show percentage of outstanding shares owned by insiders (such as key officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Also please take a look at World Market Map. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.